Evidence map›Paper›PMID 31443925›Full record

ArticleLancet (London, England)2019

Is it time to include cancer in cardiovascular risk prediction tools?

Anne H Blaes, Chetan Shenoy

Abstract readComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Epichaperome-targeted myocardial imaging byClinical and translational imaging · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Cardio-Oncology Education and Training: JACC Council Perspectives.Journal of the American College of Cardiology · 2020
    Review
  18. Article
  19. Rates of underuse of statins among cancer survivors versus controls: NHANES 2011-2016.Journal of cancer survivorship : research and practice · 2020
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Anne H BlaesDivision of Hematology/Oncology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: blaes004@umn.edu.
Chetan ShenoyDivision of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Funding

Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related CardiotoxicityK23HL132011 · NHLBI · UNIVERSITY OF MINNESOTA · PI SHENOY, CHETAN N · 2016 to 2020
$884k
NHLBI NIH HHS K23 HL132011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesNeoplasmsAdultCohort StudiesElectronic Health RecordsHumansRisk AssessmentRisk FactorsSurvivorsUnited Kingdom

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.